TY - JOUR
T1 - Primary oncocytic adenocarcinomas of the lung
T2 - A clinicopathologic, immunohistochemical, and molecular biologic analysis of 16 cases
AU - Solis, Luisa M.
AU - Raso, M. Gabriela
AU - Kalhor, Neda
AU - Behrens, Carmen
AU - Wistuba, Ignacio I.
AU - Moran, Cesar A.
PY - 2010/1
Y1 - 2010/1
N2 - Sixteen cases of primary oncocytic adenocarcinomas of the lung are reported. The patients were 11 women and 5 men between the ages of 47 and 81 years (median, 75 years) with symptoms of cough, chest pain, and shortness of breath. Surgical staging disclosed 14 patients (88%) with stage I disease, 1 (6%) with stage II, and 1 (6%) with stage III. Histologically, all the cases displayed prominent oncocytic features with conventional growth patterns, including acinar, papillary, and bronchioloalveolar. Immunohistochemically, the tumors displayed positive staining for keratin 7, thyroid transcription factor-1, and mitochondrial antibody. Molecular studies showed 3 (20%) of 15 tumors with EGFR mutations and 3 additional cases with KRAS mutations. Clinical follow-up of at least 24 months was obtained in all patients and showed that 5 patients had recurrences, 2 patients died of tumor, and 2 other patients died of unrelated conditions. These cases represent an unusual variant of pulmonary adenocarcinoma.
AB - Sixteen cases of primary oncocytic adenocarcinomas of the lung are reported. The patients were 11 women and 5 men between the ages of 47 and 81 years (median, 75 years) with symptoms of cough, chest pain, and shortness of breath. Surgical staging disclosed 14 patients (88%) with stage I disease, 1 (6%) with stage II, and 1 (6%) with stage III. Histologically, all the cases displayed prominent oncocytic features with conventional growth patterns, including acinar, papillary, and bronchioloalveolar. Immunohistochemically, the tumors displayed positive staining for keratin 7, thyroid transcription factor-1, and mitochondrial antibody. Molecular studies showed 3 (20%) of 15 tumors with EGFR mutations and 3 additional cases with KRAS mutations. Clinical follow-up of at least 24 months was obtained in all patients and showed that 5 patients had recurrences, 2 patients died of tumor, and 2 other patients died of unrelated conditions. These cases represent an unusual variant of pulmonary adenocarcinoma.
KW - Adenocarcinoma
KW - Carcinoma
KW - Immunohistochemistry
KW - Lung
KW - Oncocytic
UR - http://www.scopus.com/inward/record.url?scp=73949135041&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=73949135041&partnerID=8YFLogxK
U2 - 10.1309/AJCPOQWPT1T1AJFT
DO - 10.1309/AJCPOQWPT1T1AJFT
M3 - Article
C2 - 20023269
AN - SCOPUS:73949135041
SN - 0002-9173
VL - 133
SP - 133
EP - 140
JO - American journal of clinical pathology
JF - American journal of clinical pathology
IS - 1
ER -